J&J’s shopper well being unit Kenvue went on sale. What does it imply for the membership?

Johnson & Johnson’s (JNJ) consumer health unit Kenvue (KVUE) rose more than 22% in its first day of trading on Thursday, bringing the club holding company one step closer to completing its business split. The proposed split, slated for later this year, is in the best interests of shareholders of both Kenvue’s soon-to-be solo operations …

CEO of J&J spin-off Kenvue focuses on post-IPO innovation

Thibaut Mongon, CEO of Kenvue Inc., a Johnson & Johnson consumer health company, speaks during an interview with CNBC during his company’s initial public offering on the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Kenvue CEO Thibaut Mongon is banking on brand and product innovation to fuel the growth of …

The WHO declares the worldwide well being emergency of Covid-19 over

Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), speaks during a news conference December 20, 2021 in Geneva, Switzerland. Denis Balibouse | Reuters The spread of Covid-19 is no longer a global public health emergency, the World Health Organization said on Friday. “For more than a year, the pandemic has been on a …

CDC director Rochelle Walensky will step down in June

Rochelle Walensky, director of the Centers for Disease Control, leaves the office after speaking before the Senate Committee on Health, Education, Labor and Pensions on the All-Hazards Preparedness Act Thursday, April 4. Kent Nishimura | Los Angeles Times | Getty Images CDC Director Dr. Rochelle Walensky announced on Friday that she would step down at …

Outcomes from Moderna (MRNA) Q1 2023

Modern on Thursday topped estimates for first-quarter earnings and revenue and posted a surprise quarterly profit despite lower demand for Covid vaccines, the only marketable product. The biotech posted revenue of $1.9 billion in the first quarter, driven by Covid-shot earnings pushed back from 2022. That’s more than 60% down from the $6.1 billion it …

Eli Lilly therapy with donanemab slowed illness development

An Eli Lilly and Company pharmaceutical manufacturing facility is pictured at 50 ImClone Drive on March 50, 2021 in Branchburg, New Jersey. Fresh Mike | Reuters The Alzheimer’s treatment Donanemab, which is manufactured by Eli Lillisignificantly slowed the progression of the mind-numbing disease, according to clinical trial data released by the company on Wednesday. Patients …

Pfizer (PFE) Quarterly Report 2023

Pfizer on Tuesday reported first-quarter sales and adjusted earnings that beat Wall Street expectations, despite a decline in sales attributed to lower demand for the company’s Covid vaccine. Shares of the pharmaceutical giant were largely unchanged on Tuesday. Shares are down more than 23% for the year through Monday’s close, putting the company’s market value …

Scientists are creating an AI system that focuses on changing ideas into textual content

Alex Huth (left), Shailee Jain (center) and Jerry Tang (right) prepare to collect brain activity data at the University of Texas Biomedical Imaging Center at Austin. The researchers trained their semantic decoder using dozens of hours of participants’ brain activity data collected in an fMRI scanner. Photo: Nolan Zuk/University of Texas at Austin. Scientists have …